HomeOur ServicesConnect Education WorkshopsHomeOur ServicesConnect Education WorkshopsConnect Education Workshops About GeneticsYou can also browse all resources about genetics»Subscribe to these results:RSSUpcoming WorkshopsFor Breast CancerDec13Living with Breast Cancer - 46th Annual San Antonio Breast Cancer SymposiumPart I of Living with Breast Cancer: Updates from the San Antonio Breast Cancer SymposiumTags:breast cancermetastatic breast cancertriple negative breast cancerclinical trialsdoctor-patient communicationgeneticsgenomicsmastectomyside effectstreatmentRegisterJan17Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 46th Annual San Antonio Breast Cancer Symposium (SABCS)Part II of Living with Breast Cancer: Updates from the San Antonio Breast Cancer SymposiumTags:breast cancermetastatic breast cancertriple negative breast cancerclinical trialsdoctor-patient communicationgeneticsgenomicsmastectomyside effectstreatmentRegister Past workshops For All CancersWhat’s New in Precision MedicineTags:treatmentbiomarkersgeneticsgenomicsimmunotherapypersonalized medicinetargeted treatmentsWhat’s New in Diagnostic Technologies for People Living with Solid Cancer TumorsPart I of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with CancerTags:diagnostic testsgeneticspersonalized medicinetargeted treatmentsFor Breast CancerWhat’s New in Precision MedicineTags:breast cancerchronic lymphocytic leukemiachronic myelogenous leukemiacolorectal cancercutaneous t-cell lymphomadiffuse large b-cell lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkerscar t-cell therapydiagnostic testsgeneticsgenomicsimmunotherapytargeted treatmentsUpdates from the 45th Annual San Antonio Breast Cancer Symposium on Triple Negative Breast CancerTags:breast cancermetastatic breast cancertriple negative breast cancerblack or african americanhealth care disparitiesbiomarkersclinical trialsdiagnostic testsgeneticstreatmentHER2-Positive Metastatic Breast Cancer: What’s New in Treatment & Quality-of-LifeTags:breast cancermetastatic breast cancertriple negative breast canceradherencebiosimilarscar t-cell therapychemotherapyclinical trialsimmunotherapymastectomytargeted treatmentstreatmentbiomarkersdiagnostic testsgeneticsside effectsFor Chronic Lymphocytic LeukemiaWhat’s New in Precision MedicineTags:breast cancerchronic lymphocytic leukemiachronic myelogenous leukemiacolorectal cancercutaneous t-cell lymphomadiffuse large b-cell lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkerscar t-cell therapydiagnostic testsgeneticsgenomicsimmunotherapytargeted treatmentsFor Chronic Myelogenous LeukemiaWhat’s New in Precision MedicineTags:breast cancerchronic lymphocytic leukemiachronic myelogenous leukemiacolorectal cancercutaneous t-cell lymphomadiffuse large b-cell lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkerscar t-cell therapydiagnostic testsgeneticsgenomicsimmunotherapytargeted treatmentsFor Colorectal CancerWhat’s New in Precision MedicineTags:breast cancerchronic lymphocytic leukemiachronic myelogenous leukemiacolorectal cancercutaneous t-cell lymphomadiffuse large b-cell lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkerscar t-cell therapydiagnostic testsgeneticsgenomicsimmunotherapytargeted treatmentsAdvances in the Treatment of Colorectal CancerTags:colorectal canceradherencebiomarkerschemotherapyclinical trialshealth care disparitiesimmunotherapypersonalized medicinetargeted treatmentstreatmentgeneticsgenomicsdiagnostic testsColorectal Cancer Treatment: Progress & AdvancesTags:colorectal cancertreatmentbiomarkersdiagnostic testsgeneticsgenomicsimmunotherapypersonalized medicinetargeted treatmentsclinical trialsFor Cutaneous T-Cell LymphomaWhat’s New in Precision MedicineTags:breast cancerchronic lymphocytic leukemiachronic myelogenous leukemiacolorectal cancercutaneous t-cell lymphomadiffuse large b-cell lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkerscar t-cell therapydiagnostic testsgeneticsgenomicsimmunotherapytargeted treatmentsFor Diffuse Large B-Cell LymphomaWhat’s New in Precision MedicineTags:breast cancerchronic lymphocytic leukemiachronic myelogenous leukemiacolorectal cancercutaneous t-cell lymphomadiffuse large b-cell lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkerscar t-cell therapydiagnostic testsgeneticsgenomicsimmunotherapytargeted treatmentsFor Hodgkin LymphomaWhat’s New in Precision MedicineTags:breast cancerchronic lymphocytic leukemiachronic myelogenous leukemiacolorectal cancercutaneous t-cell lymphomadiffuse large b-cell lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkerscar t-cell therapydiagnostic testsgeneticsgenomicsimmunotherapytargeted treatmentsFor LeukemiaWhat’s New in Precision MedicineTags:breast cancerchronic lymphocytic leukemiachronic myelogenous leukemiacolorectal cancercutaneous t-cell lymphomadiffuse large b-cell lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkerscar t-cell therapydiagnostic testsgeneticsgenomicsimmunotherapytargeted treatmentsFor LymphomaWhat’s New in Precision MedicineTags:breast cancerchronic lymphocytic leukemiachronic myelogenous leukemiacolorectal cancercutaneous t-cell lymphomadiffuse large b-cell lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkerscar t-cell therapydiagnostic testsgeneticsgenomicsimmunotherapytargeted treatmentsFor Mantle Cell LymphomaWhat’s New in Precision MedicineTags:breast cancerchronic lymphocytic leukemiachronic myelogenous leukemiacolorectal cancercutaneous t-cell lymphomadiffuse large b-cell lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkerscar t-cell therapydiagnostic testsgeneticsgenomicsimmunotherapytargeted treatmentsFor Marginal Zone LymphomaWhat’s New in Precision MedicineTags:breast cancerchronic lymphocytic leukemiachronic myelogenous leukemiacolorectal cancercutaneous t-cell lymphomadiffuse large b-cell lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkerscar t-cell therapydiagnostic testsgeneticsgenomicsimmunotherapytargeted treatmentsFor Metastatic Breast CancerWhat’s New in Precision MedicineTags:breast cancerchronic lymphocytic leukemiachronic myelogenous leukemiacolorectal cancercutaneous t-cell lymphomadiffuse large b-cell lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkerscar t-cell therapydiagnostic testsgeneticsgenomicsimmunotherapytargeted treatmentsUpdates from the 45th Annual San Antonio Breast Cancer Symposium on Triple Negative Breast CancerTags:breast cancermetastatic breast cancertriple negative breast cancerblack or african americanhealth care disparitiesbiomarkersclinical trialsdiagnostic testsgeneticstreatmentHER2-Positive Metastatic Breast Cancer: What’s New in Treatment & Quality-of-LifeTags:breast cancermetastatic breast cancertriple negative breast canceradherencebiosimilarscar t-cell therapychemotherapyclinical trialsimmunotherapymastectomytargeted treatmentstreatmentbiomarkersdiagnostic testsgeneticsside effectsFor Non-Hodgkin LymphomaWhat’s New in Precision MedicineTags:breast cancerchronic lymphocytic leukemiachronic myelogenous leukemiacolorectal cancercutaneous t-cell lymphomadiffuse large b-cell lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkerscar t-cell therapydiagnostic testsgeneticsgenomicsimmunotherapytargeted treatmentsFor Peripheral T-Cell LymphomaWhat’s New in Precision MedicineTags:breast cancerchronic lymphocytic leukemiachronic myelogenous leukemiacolorectal cancercutaneous t-cell lymphomadiffuse large b-cell lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkerscar t-cell therapydiagnostic testsgeneticsgenomicsimmunotherapytargeted treatmentsFor Small Lymphocytic LymphomaWhat’s New in Precision MedicineTags:breast cancerchronic lymphocytic leukemiachronic myelogenous leukemiacolorectal cancercutaneous t-cell lymphomadiffuse large b-cell lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkerscar t-cell therapydiagnostic testsgeneticsgenomicsimmunotherapytargeted treatmentsFor Triple Negative Breast CancerWhat’s New in Precision MedicineTags:breast cancerchronic lymphocytic leukemiachronic myelogenous leukemiacolorectal cancercutaneous t-cell lymphomadiffuse large b-cell lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkerscar t-cell therapydiagnostic testsgeneticsgenomicsimmunotherapytargeted treatmentsUpdates from the 45th Annual San Antonio Breast Cancer Symposium on Triple Negative Breast CancerTags:breast cancermetastatic breast cancertriple negative breast cancerblack or african americanhealth care disparitiesbiomarkersclinical trialsdiagnostic testsgeneticstreatmentHER2-Positive Metastatic Breast Cancer: What’s New in Treatment & Quality-of-LifeTags:breast cancermetastatic breast cancertriple negative breast canceradherencebiosimilarscar t-cell therapychemotherapyclinical trialsimmunotherapymastectomytargeted treatmentstreatmentbiomarkersdiagnostic testsgeneticsside effects